Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Medical Genetics

Is Hereditary Fructose Intolerance Passed to Children?

At a Glance

A person with hereditary fructose intolerance passes one disease-causing ALDOB variant to every child, but a child develops HFI only if the other parent also passes an ALDOB variant. Partner testing and genetic counseling clarify each pregnancy's risk.

If you have hereditary fructose intolerance (HFI), you will not automatically pass the condition on to your children. HFI is a genetic disorder that follows an autosomal recessive inheritance pattern [1]. This means that for a child to be born with HFI, they must inherit two copies of the ALDOB gene that have disease-causing (pathogenic) variants—one from each parent [2]. Because you have HFI, you will pass on one copy with a pathogenic variant to each of your children, but whether they actually develop the condition depends heavily on the genetics of your reproductive partner [1].

Understanding the Genetics of HFI

HFI is caused by variants in the ALDOB gene, which provides the instructions for making the enzyme aldolase B [1].

  • Variant: A change in the DNA sequence of a gene. A “pathogenic variant” means the change is known to cause disease.
  • Carrier: Because we all inherit two copies of the ALDOB gene (one from each parent), a person with one pathogenic copy and one functioning copy is a “carrier.” Carriers typically do not have HFI and usually do not experience symptoms, but they can pass the pathogenic variant to their children [1].

People with HFI have pathogenic variants in both copies of their ALDOB gene [1][2].

What Are the Chances for Your Children?

Because you have HFI, all of your children will inherit one ALDOB copy with a pathogenic variant from you. The chance of a child having HFI depends on whether your partner also carries a pathogenic variant.

It is important to remember that the percentages below apply independently to each pregnancy. A 50% chance does not mean half of your family will be affected; it means every time you have a child, that specific child has a 50% chance.

Your Status Your Partner’s Status Chance of Child Having HFI (per pregnancy) Chance of Child Being an Unaffected Carrier (per pregnancy)
Has HFI Not a carrier (no variant detected) Greatly reduced (near 0%)* ~100%
Has HFI Is a carrier 50% 50%
Has HFI Also has HFI 100% 0%

* Note: If comprehensive testing finds no pathogenic ALDOB variant in your partner, the risk is greatly reduced. However, because no genetic test is 100% perfect at detecting every possible rare variant, the residual risk is not absolutely zero. A genetics professional can explain what this residual risk means for your family. [3]

The Role of Genetic Testing and Counseling

Determining the risk to your future children begins with confirming your own genetics. A clinical diagnosis of HFI should ideally be confirmed with molecular testing to identify your specific ALDOB variants [1][4].

Once your variants are known, your partner can undergo testing. The type of testing matters:

  • Targeted testing: If your familial variants are known, or if the clinic is checking for the most common variants in your population, they may use a targeted screen [3].
  • Comprehensive testing: A basic screen for common variants might miss a rarer mutation. In some cases, comprehensive sequencing of the ALDOB gene (and sometimes deletion/duplication analysis) is needed to more accurately determine your partner’s carrier status [3].

Meeting with a genetic counselor can help you navigate these options. They can coordinate the most appropriate testing, interpret the results (including any “variants of uncertain significance”), and discuss your reproductive choices in a non-directive way [5][6]. These options might include prenatal testing, preimplantation genetic testing, donor gametes, adoption, or choosing not to have biological children.

Safety Plan for Your Baby

Because HFI is not routinely included in standard newborn screening programs in many areas, you should not rely on a routine heel-prick test to rule it out [7].

If your baby’s genetic status is unknown at birth (for example, if your partner was found to be a carrier or was not comprehensively tested), it is critical to have a safety plan in place before the baby is born:

  • Inform your care team: Alert your obstetric and pediatric teams that your baby is at risk for HFI. They should arrange early consultation with a pediatric metabolic specialist or geneticist [8].
  • Control early exposures: A baby with HFI can develop life-threatening acute liver failure if given formula or medications containing fructose, sucrose, or sorbitol [9]. The medical team must carefully check all feeding products, formulas, and medications (including liquid vitamins) until the baby’s genetic status is clarified [10][11].
  • Never test through diet: Do not deliberately expose your baby to fructose or sucrose to see if they react. Testing should be done through genetic analysis [9][8].
  • Watch for symptoms: If an accidental exposure occurs, symptoms like sweating, nausea, vomiting, lethargy, poor feeding, or jaundice (yellowing of the skin/eyes) require immediate medical assessment [9][12].

Common questions in this guide

If I have HFI, will every child I have develop it?
No. A person with HFI passes one pathogenic ALDOB variant to every child, but the child develops HFI only if the other parent also passes a pathogenic ALDOB variant. If the other parent is not a carrier, the children are generally expected to be unaffected carriers, although testing cannot reduce the risk to absolutely zero.
What is the chance of HFI if my partner is a carrier?
If one parent has HFI and the other parent carries one pathogenic ALDOB variant, each pregnancy has a 50% chance of HFI and a 50% chance of being an unaffected carrier. These chances apply independently to every pregnancy and do not predict how many children in a family will be affected.
What if both parents have hereditary fructose intolerance?
If both parents have HFI, each parent has two pathogenic ALDOB variants and passes a pathogenic variant to every child. In that situation, each child has a 100% chance of having HFI.
Should my partner have genetic testing before we have children?
Yes, partner testing can clarify the chance of a child having HFI. Testing may be targeted to known family variants or may involve more comprehensive ALDOB sequencing and deletion or duplication analysis; a genetic counselor can help choose and interpret the testing.
How can we protect a baby whose HFI status is not known at birth?
Tell the obstetric and pediatric teams before delivery that the baby may be at risk, and ask a pediatric metabolic specialist or geneticist to help plan care. Until genetic status is clarified, the team should check formulas, foods, and medicines for fructose, sucrose, and sorbitol; the baby should never be deliberately exposed to test for HFI.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Have my specific ALDOB gene variants been identified, and is a copy of my genetic report available for my reproductive partner's care team?
  2. 2.Based on my genetic results, what type of carrier testing (targeted vs. comprehensive sequencing) do you recommend for my partner?
  3. 3.Can you refer us to a genetic counselor to discuss our family planning, testing options, and the residual risks after testing?
  4. 4.If my partner is a carrier, what prenatal or preimplantation testing options are available to us?
  5. 5.How do we coordinate with a pediatric metabolic specialist to ensure our newborn's formula and hospital medications will be safe from birth?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Genotypic and Phenotypic Characteristics of Turkish Patients with Hereditary Fructose Intolerance.

    Kılıç M, Sayar E, İcil S, Sezer A

    Molecular syndromology 2026; doi:10.1159/000551573.

    PMID: 42164825
  2. 2

    Epidemiological aspects of hereditary fructose intolerance: A database study.

    Pinheiro FC, Sperb-Ludwig F, Schwartz IVD

    Human mutation 2021; (42(12)):1548-1566 doi:10.1002/humu.24282.

    PMID: 34524712
  3. 3

    Fructosuria and recurrent hypoglycemia in a patient with a novel c.1693T>A variant in the 3' untranslated region of the aldolase B gene.

    Morales-Alvarez MC, Ricardo-Silgado ML, Lemus HN, et al.

    SAGE open medical case reports 2019; (7()):2050313X18823098 doi:10.1177/2050313X18823098.

    PMID: 30675358
  4. 4

    Hereditary fructose intolerance: A comprehensive review.

    Singh SK, Sarma MS

    World journal of clinical pediatrics 2022; (11(4)):321-329 doi:10.5409/wjcp.v11.i4.321.

    PMID: 36052111
  5. 5

    A Case Study of a Rare Disease (Fructosemia) Diagnosed in a Patient with Abdominal Pain.

    Garbowski L, Walasek M, Firszt R, et al.

    Journal of clinical medicine 2024; (13(12)) doi:10.3390/jcm13123394.

    PMID: 38929922
  6. 6

    Pitfalls in the Diagnosis of Hereditary Fructose Intolerance.

    Kim AY, Hughes JJ, Pipitone Dempsey A, et al.

    Pediatrics 2020; (146(2)) doi:10.1542/peds.2019-3324.

    PMID: 32709737
  7. 7

    Estimation of hereditary fructose intolerance prevalence in the Chinese population.

    Tang M, Chen X, Ni Q, et al.

    Orphanet journal of rare diseases 2022; (17(1)):326 doi:10.1186/s13023-022-02487-3.

    PMID: 36028839
  8. 8

    Neonatal Hereditary Fructose Intolerance: Diagnostic Misconceptions and the Role of Genomic Sequencing.

    Lee J, Arenth J, Kasi N

    JPGN reports 2021; (2(2)):e076 doi:10.1097/PG9.0000000000000076.

    PMID: 37207065
  9. 9

    Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas.

    Li H, Byers HM, Diaz-Kuan A, et al.

    Molecular genetics and metabolism 2018; (123(4)):428-432 doi:10.1016/j.ymgme.2018.02.016.

    PMID: 29510902
  10. 10

    KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword.

    Pinheiro FC, Sperb-Ludwig F, Schwartz IVD

    Cellular and molecular life sciences : CMLS 2020; (77(17)):3465-3466 doi:10.1007/s00018-020-03575-y.

    PMID: 32591859
  11. 11

    Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance.

    Izquierdo-García E, Lázaro-Cebas A, Montero Pastor B, et al.

    Orphanet journal of rare diseases 2024; (19(1)):12 doi:10.1186/s13023-023-03011-x.

    PMID: 38183105
  12. 12

    Hereditary fructose intolerance mimicking a biochemical phenotype of mucolipidosis: A review of the literature of secondary causes of lysosomal enzyme activity elevation in serum.

    Ferreira CR, Devaney JM, Hofherr SE, et al.

    American journal of medical genetics. Part A 2017; (173(2)):501-509 doi:10.1002/ajmg.a.38023.

    PMID: 27797444

This page is for informational purposes only and does not constitute medical advice. A genetic counselor and your medical team can help interpret your results and plan pregnancy or newborn care.

Get notified when new evidence is published on Hereditary fructose intolerance.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.